Many homeowners struggling financially in the coronavirus pandemic worry mortgage servicers will require them to repay mortgage bills all at once.

Shareholders will be ecstatic, with their stake up 30% over the past week following ObsEva SA's (NASDAQ:OBSV) latest...

(Bloomberg) -- Wall Street’s biggest firms are divided on where markets are heading to next.While most risk assets are well off their mid-March lows, when uncertainty about the global impact of the coronavirus outbreak was at its peak, there is little consensus on what is to follow. At the core of the debate is the long-term effectiveness of the massive stimulus from central banks and governments.When $8 Trillion in Global Fiscal Stimulus Still Isn’t EnoughCitigroup Inc., for one, doesn’t get the “puzzling” rise in stocks.“Extensive policy response, led by ample liquidity provided by central banks, likely contributed to the move in the markets,” economists including Igor Cesarec and Catherine Mann wrote in a note Thursday. “However, since it is not clear that markets can be propped up indefinitely, caution is warranted. Risk assets could be fragile once the cold, hard economic reality hits again.”On the other hand, JPMorgan Chase & Co. sees the stock market advance as justified -- and one which can continue.“While the collapse in economic activity is historic, so too is the global policy response to cushion the impact and support a recovery,” strategists led by Marko Kolanovic wrote in a note Thursday. “We expect risky assets to continue to recover as economies reopen and given the unprecedented policy support, though we expect a moderation in the pace of gains.”Read about JPMorgan’s call in late March that markets were probably past the worst.The MSCI AC World Index has climbed about 25% since March 23 as investor sentiment warmed toward a slew of worldwide policy measures to offset the economic impact of the pandemic. The global gauge had fallen as much as 34% from its February high, when concerns about the virus reached a peak.Looking ForwardGoldman Sachs Group Inc. and Morgan Stanley largely see gains remaining intact, with caveats.Goldman attributes the market rise to a stabilization in virus infection rates and an improvement in measures of funding and liquidity stress. The firm has already said that equities price in macroeconomic performance over a two-year time horizon and investors may look past huge economic damage.“Markets will continue to look through bad news about the depth of the economic downturn if they can continue to hold on to their view that a sizable chunk of the recent damage will be reversed by the end of next year,” strategists including Zach Pandl wrote in a note Tuesday.And Morgan Stanley is also comfortable with the disparity between asset price performance and fundamentals, noting that markets tend to lead the economy and care more about rate of changes than absolute levels.“Divergences between the market and economy are common at economic extremes,” wrote strategists including Andrew Sheets in a note Thursday. “Rate of change is key – a ‘U’ shaped recovery is fine, a ‘W’ is not.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

The following is a brief roundup of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. A new antibody test is highly accurate at determining whether people have been infected with the novel coronavirus, according to a study published on Friday in The Journal of Clinical Microbiology. Researchers at the University of Washington School of Medicine found the test, manufactured by Abbott Laboratories, had a specificity rate of 99.9% and a sensitivity rate of 100%, suggesting little chance of incorrectly diagnosing a healthy person as having been infected and virtually no chance of a false negative readout.

Investors in Clean Energy Fuels Corp. (NASDAQ:CLNE) had a good week, as its shares rose 6.3% to close at US$2.11...

As of Thursday evening, more than 40 percent of the funds remained available in the Paycheck Protection Progam

The analysts might have been a bit too bullish on Consolidated Edison, Inc. (NYSE:ED), given that the company fell...

Could we see the yellow metal at $5,000 or even higher amid the coronavirus crisis? We invite you thus to read our today’s article and find out how high gold prices can go in this downturn.

Each decade has an investment theme that favors one asset class over another. What performed well over the last decade generally underperforms during the next.

Director of Fiscal Policy at the American Action Forum Gordon Gray joins Yahoo Finance’s Seana Smith to break down the April jobs report and how some workers are making more on unemployment compared to their wages before the coronavirus pandemic.

Biopharma shares have outperformed the broader market year-to-date, giving rise to apprehension over whether a pullback is in the offing. An analyst at BofA Securities said Friday that now is the time to go from defensive to offensive in the sector, as quarantines are winding down in several parts of the globe.The Biopharma Analyst Analyst Geoff Meacham shortlisted Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Bristol-Myers Squibb Co (NYSE: BMY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Amgen, Inc. (NASDAQ: AMGN) as biopharma stocks where he would put his money to work.The analyst has the following ratings and price targets for the shares: * Lilly: Buy/$165 * Vertex: Buy/$300 * Bristol-Myers Squibb: Buy/raised the price target from $75 to $80 * BioMarin: Buy/lifted price target from $110 to $120 * Amgen: Buy/price target increased from $265 to $2755 Reasons For BofA's Bullish Disposition BofA is increasingly bullish on the biopharma group due to the following factors, Meacham said: * Expectations for robust revenue growth of 6% in the second half of 2020 compared to the first-half, which is double that of the S&P 500's revenue growth. * Reasonable price-earnings for the stocks in the sector. * Many value-creating events lined up for the second half. * Lower policy risk stemming from goodwill earned from the COVID-19 pipeline. * A consistently positive FDA backdrop.Q1 Earnings Get 'A' Grade All of the big biotechs and major pharma companies reported both revenue and adjusted EPS beats in the first quarter, with Lilly and Vertex even raising some parts of their 2020 guidance, Meacham said.Citing slower new starts and forex headwinds, Bristol-Myers Squibb and BioMarin lowered their 2020 revenue guidance, but maintained their EPS guidance, the analyst said. Meacham expressed surprise at Merck & Co., Inc. (NYSE: MRK) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) lowering their 2020 revenue and adjusted EPS guidance, given his belief that oncology or orphan diseases wouldn't be as sensitive to COVID-19 disruption.See also: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Lilly One of The Higher Quality Stocks In BofA's Coverage Lilly is a source of differentiated growth given its early product cycle and diversified base business, including diabetes, immunology and immunotoxicology and migraine, and an advancing late-stage pipeline of potentially best-in-class or first-in-class therapies, Meacham said.The analyst said he likes Lily's potential for additional earnings growth in 2020-2021 and views Lilly as one of the higher quality stocks in his coverage despite its higher valuation. The prospects for 2021 look attractive, with selpercatinib potentially launching in non-small cell lung cancer and thyroid cancer by year's end, and tirzepatide approval in 2021 representing a "step change" for the diabetes franchise, he said. Consensus For Vertex To Move Higher? Vertex has a richer -- though well-deserved -- valuation, due to its differentiated growth profile, Meacham said.Given that Vertex's commercial execution is largely unaffected by the COVID-19 pandemic, the analyst said investors will begin to look forward to 2021 sooner than for other companies with more commercial risk.BofA expects consensus estimates to continue to move higher, making Vertex's valuation even more attractive.Bristol-Myers Has Highly Differentiated Growth With an estimated 8% revenue growth and 19% EPS growth in 2021 compared to 5-6% and 12%, respectively, for peers, and with six new launches expected this year, 2020 is shaping up to be a very robust period for Bristol-Myers despite the ongoing COVID-19 headwinds, Meacham said. The analyst said the company's growth looks highly differentiated.An increasingly diversified product mix and beatable launch expectations position the company for meaningful upside to consolidated P&L, with improving synergies, he said. BioMarin's 'Game-Changing' Late-Stage Pipeline BioMarin's late-stage pipeline in valrox and vosoritide have improved its growth outlook, Meacham said.The analyst termed the company's late-stage pipeline as "game-changing." The second-half launch of Roctavian is the most important catalyst for the company this year, with the product likely to accelerate the company's already above-average growth profile, he said. "We see BioMarin as one of the higher quality names in our coverage universe given its clean growth story and it remains our SMid cap top pick." Amgen Looks To New Product Growth To Compensate For Legacy Product Erosion The long-term outlook for Amgen's Otezla is improving given the recently announced Phase 3 data for mild-to-moderate psoriasis, Meacham said.The company rapidly refocused its story from legacy product erosion to new product growth with the acquisition of Otezla from the Bristol/Celgene deal, the analyst said. "Since then Amgen's growth profile has only improved, led by an expanded addressable market for Otezla, outperforming Amgen Biosimilars and Evenity franchises, aggressive formulary negotiation for Aimovig, and an exciting pipeline in AMG 510 and tezepelumab looking to contribute as soon as 2021." The Price Action The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) was last seen trading up 1.25% to 128.76, adding to its 5.6% year-to-date gain. Related Link: The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace See more from Benzinga * The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda * The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500 * The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Retailers that were already ailing before the coronavirus are beginning to crumble as the crisis raises the threat of store closings and bankruptcy.

Moody’s Analytics analyzed U.S. metro areas capabilities for a strong recovery post-coronavirus using two primary factors: population density and educational attainment.

Many U.S. airliners are "reasonably confident" that a return to 30% to 50% of pre-COVID-19 capacity by the end of 2020 is possible, Boeing Co (NYSE: BA) CEO David Calhoun said in a Fox Business interview Friday. A 'Crawl Back' For Airline Industry Investors expecting a swift return to 2019 traffic levels may be disappointed, as the industry will "slowly crawl back" to pre-crisis levels over a three-year period, Calhoun said.It will take another two years afterward for the industry to resume the growth curve seen over the past 20 years, the CEO said. The timeline could change based on different factors, including a quicker-than-expected development of a COVID-19 vaccine that results in a "more robust" recovery, he said.Boeing 737 MAX Update The pandemic is far from Boeing's only problem to deal with, as the two 737 MAX crashes set the company back two years, Calhoun said.The company continued to manufacture new MAX planes, and even if they are grounded today, the planes will ultimately "find their way into the market."Any near-term market share losses will be erased as the MAX undergoes a "catchup" phase, he said.Boeing's talks with the FAA regarding the certification process are "constructive" and "thorough," Calhoun said.The work-from-home and travel restrictions do add by default additional time to any eventual certification for the MAX to return to the skies, the CEO said. Boeing also expects to resume 737 MAX production this month after it was suspended in January, he said. The company has already announced its plans to build fewer planes moving forward to compensate for its existing inventory.Boeing's Bond Deal Boeing already suspended its dividend and will prioritize the payback of its new $25-billion bond issue until "we get back to the same kind of balance sheet" that existed prior to the MAX crashes, he said. After that, the company will plan on how to resume cash distributions to shareholders, Calhoun said -- but not until Boeing "significantly" pays down debt. Boeing shares were trading 3.27% higher at $132.86 at the time of publication Friday.Related Links:Boeing's Large Bond Deal Solves Liquidity Problem, Says Bullish Goldman SachsBoeing Analyst Turns Bullish After Deep Sell-OffSee more from Benzinga * Southwest Airlines CEO On 'Breathtaking' March Declines, Financial Plans * Boeing Shares Lose Altitude On New Coronavirus-Driven Concerns * Carly Fiorina Blasts Corporate Bailout Funding In T Coronavirus Relief Bill(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

What happened to my stimulus money? Many who receive government benefits and others continue to wonder in early May.

Moderna CEO Stephane Bancel stated that the company’s new coronavirus vaccine, which was clear for a phase 2 trial on Thursday by the FDA, would not be ready for immediate release to the public and that the distribution of the potential vaccine would need to be handled carefully between Moderna and the White House. Yahoo Finance’s Anjalee Khemlani joins The Final Round panel to break down the latest news about the coronavirus.

Stocks that trade under $5 per share are often referred to as penny stocks. Many penny stocks trade for literal pennies (or less) on the OTC market, but there are plenty of penny stocks that trade on major exchanges as well.The Nasdaq and NYSE require all stocks listed on their exchanges to maintain a minimum share price of $1 or risk being delisted. Most companies do not want their shares trading under , so there's a good chance the large majority of penny stocks have been through some tough times. But that doesn't mean there are no penny stock buying opportunities as well.Here are eight penny stocks to buy, hold and sell, according to Bank of America.Lloyds Banking Group PLC (NYSE: LYG) - Sell Lloyds Banking Group has a market cap of more than $100 billion and is one of the largest banks in the UK, but you wouldn't know it by its $1.50 stock price. Lloyds shares are down another 53% in the past year as the bank struggles to deal with historically low interest rates.Analyst Rohith Chandra-Rajan recently said Lloyds' first quarter numbers were bad across the board, but given income and credit quality pressures, things could get even worse in the second quarter. For now, Lloyds has adequate capital, but the company's revenue outlook will have to significantly improve before the stock is investable, Chandra-Rajan said.Bank of America has an Underperform rating and $1.28 price target for LYG stock.See Also: 11 Reasons Billionaire Investor Leon Cooperman Is Worried About Long-Term Impacts Of COVID-19Nokia Oyj (NYSE: NOK) - Buy Nokia is a telecom network infrastructure equipment supplier. The stock is down 29.3% in the past year, but analyst Tal Liani recently said the company's first-quarter numbers were solid.Looking ahead, Liani said 5G demand should ramp up in the second half of the year, and Nokia has significant opportunities to improve its margins and turn around its slumping business. In the first quarter, Networks gross margins were up 3.5% from a year ago to above 30%. Liani said Nokia is far from a growth story given sales will likely be down 3.4% in 2020, but the stock has self-help upside potential.Bank of America has a Buy rating and $4.80 price target for NOK stock.Ford Motor Company (NYSE: F) - Buy Ford shares have spent most of the last six weeks trading right around $5. The global auto industry has been decimated by the coronavirus outbreak.Ford reported a $2 billion first-quarter loss and guided for another $5 billion loss in the second quarter. However, analyst John Murphy said Ford has done a good job in shoring up its balance sheet by drawing $15.4 billion on its revolving credit facility and raising $8 billion via an unsecured senior notes offering. Murphy said Ford will likely emerge from the economic downturn a stronger company, and the economic pressures have likely hastened Ford's restructuring and cost-cutting efforts.Bank of America has a Buy rating and $7 price target for F stock.Nio Inc - ADR (NYSE: NIO) - Buy After a brutal 2019, shares of Chinese electric vehicle maker Nio have gained 81.6% so far in 2020 but remain priced under $4. Analyst Ming Hsun Lee recently upgraded Nio.In the midst of a brutal global auto market, Nio reported 3,155 deliveries in April, up 181% from a year ago and 106% from March. Lee said Nios recent fundraising has reduced cash burn fears and sales growth should help boost margins over time. Lee also said the recently announced EV purchase subsidy scheme demonstrates that the Chinese government intends to help support the company.Bank of America has a Buy rating and $5 price target for Nio stock.Southwestern Energy Company (NYSE: SWN) - Sell Southwestern Energy is one of the largest natural gas producers in the U.S. The oil market has been devastated by the economic shutdown, but natural gas prices have actually been relatively stable year-to-date. Still, analyst Doug Leggate recently said core Marcellus inventory depth is a concern for the company.Southwestern could also be at risk of exceeding its net leverage requirements under its 2018 debt covenants. Shares are up 80% in the past three months on the expectation that less U.S. oil production will limit associated gas supply, but Leggate said the impact may be smaller than investors realize.Bank of America has an Underperform rating and $1.85 price target for SWN stock.Transocean LTD (NYSE: RIG) - Sell Transocean is one of the world's largest offshore oil drilling contractors. Transocean has been one of the worst investments in the market over the past decade, and shares are down 98% overall during that period. Unfortunately, analyst Mike Sabella recently said there seems to be no end in sight for Transocean's troubles.Sabella said there is essentially no demand for offshore drilling, and a severe lack of capital will likely force cold stacking and scrapping of existing rigs. Leverage and free cash flow problems will likely continue to plague the company for years to come.Bank of America has an Underperform rating and $1 price target for RIG stock.See Also: 7 Best-Performing Stocks Of 2020: Buy, Sell Or Hold?J C Penney Company Inc (NYSE: JCP) - Sell Twenty years ago, it would have seemed inconceivable that JC Penney shares would be trading at 18 cents. Yet here we are. Less than two years after Sears was delisted, JC Penney is a true penney stock and appears to be headed down the same path.Even prior to the coronavirus outbreak, same-store sales dropped 7% in the fourth quarter and the company guided for up to a 4.5% drop in 2020. Analyst Lorraine Hutchinson recently said JC Penney simply can't seem to stop the bleeding, and the stock is untouchable unless the company somehow finds a way for its business to make a 180-degree turn fast.Bank of America has an Underperform rating and 20-cent price target for JCP stock.Photo credit: Miosotis Jade, via Wikimedia CommonsLatest Ratings for F DateFirmActionFromTo Apr 2020Goldman SachsInitiates Coverage OnNeutral Mar 2020Morgan StanleyMaintainsOverweight Mar 2020CitigroupMaintainsNeutral View More Analyst Ratings for F View the Latest Analyst Ratings See more from Benzinga * How Trading In Ford, GE And Other Volatile Stocks Could Be Linked To Casino Closures * Hedge Fund Manager Makes Bold Tesla Prediction Ahead Of Earnings * Ford Analysts React To Earnings: 'Potential Liquidity Crunch Looming'(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

General Electric (GE) shares have been on the decline as of late. As a result, many investors have been understandably worried. Such sentiments have placed the American manufacturing giant on the market spotlight, and begs the question: is it still worth investing in at current levels? Traversing turbulent market conditions, the outlook seems bleak for the 128-year-old conglomerate. Is there no way up for the aviation unit of General Electric? What about its other subsidiaries? Investor James Richman bets GE is likely to touch down $5-level. From there, the tech investor is bullish that the price will double in value and hit $10 again.Source: Flickr GE: a legacy of over 120 yearsAmid the impact of coronavirus specifically in both travel and hospitality industries, GE's esteemed aviation unit has been feeling the most pressure. The demand for airplanes has shrunk tremendously forcing the company's management to schedule a 25% workforce reduction globally. This is in consonance to the 10% layoff in its US workforce which was announced in March. These difficult cost-cutting measures are deemed necessary by David Joyce, CEO of the GE Aviation Unit that employs a workforce of around 52,000 people.Significant drops since coronavirusGE Aviation supplies jet engines to giant aircraft makers like Airbus and Boeing. The projection of Boeing, a 10% workforce drop amidst its $641m loss, certainly adds up to GE's current woes.  Investor betting on the company bouncing backHowever, one investor who is known to take a different outlook is Latvian-born investor James Richman. With investments in both public and private companies, and his most notable investments including tech giants such as Uber, Tesla, and Facebook, his approach is understood to be contrarian. Yahoo! Finance reports he is taking the opposite approach when compared to Warren Buffet as Richman bets GE's price to temporarily touch upon $5-level. From that level, it is projected to climb its way back to $10, making the 100% rally. The Monaco-based investor has also made headlines when he reportedly pledged $18m in the fight against coronavirus as he mobilizes his biomedical investments in the said efforts. Richman has been historically known to take the contrarian approach in investing. With investments that seemed unorthodox at one point, he has earned respect in the finance field because of his firm's outstanding performance during the 2008 financial crisis. Not open to the general public and mainly dealing with ultra high net worth individuals (UHNWI) and institutional investors, his clients have reported impressive annual earnings for over a decade.Comparison to the last financial crisisIt is not the first time GE had felt the backlash of market recessions. In 2008, the company's shares dropped by 78% tracing the period of the global recession. In 2 years, GE's shares dropped from $27 to $6. The broader S&P also fell that time, but with a conservative 51%.Still worth buying at current levels?GE recovered from the 2008 recession with tremendous momentum. After being bailed out by the federal government to the tune of $139 billion, it experienced an 82% uptick between March 2009 and January 2010. This is more than the 48% bounce back the S&P managed over the same period. Generally, the performance of its stock will still hinge on the developments in the handling of coronavirus pandemic, considering that the aviation division of the company is being hammered as a result. Efforts of which have been showing positive signs of recovery. Meanwhile, the demand for healthcare, government interventions, and the continuous development of treatments and vaccines is seen to help push the shares towards upwards direction in the long run: provided that its wings can weather the storm like it did in 2008.  More recent articles from Smarter Analyst: * RBC: 2 Strong Value Stocks to Buy Now * Look Beyond 2Q, General Motors Will Outperform the Sector, Says Analyst * Coronavirus Vaccine Could Add Massive Value to This Small-Cap Stock, Says Analyst * Can Seanergy Maritime Stock Add 150% Over the Next Year? This Analyst Says 'Yes'

Investors are still uncertain just where the stock market is headed. Essentially, there are two competing opinions right now. One says that we’re just in a bear market rally, and that the worst is yet to come. The other thesis states that the current rally is real, and will mature into a new bull cycle as the economy restarts in the second half.Writing from JPMorgan, Marko Kolanovic, the investment bank's quant analyst, holds fast to that optimistic view. Kolanovic believes that epidemiological data suggests we are past the worst of the coronavirus spread, justifying the lifting of social and business restrictions. And that will open up economic activity, which will then find stimulus from low Fed interest rates and increased government ‘pump priming’ spending.Kolanovic sees the stimulus policies as more important than Q1’s weak earnings, writing, “The combined suppression of the risk free rate and credit spreads by the Fed likely has a bigger positive impact on equity valuation, compared with the negative impact of the temporary earnings loss.”Kolanovic is not the only JPM analyst who sees potential in the stock markets. The firm’s equity analysts have been working overtime to find the stocks best positioned to lead a potential bull rally. We’ve used the TipRanks database to pull up three of their stock picks, to find out why the JPM experts are tapping them for over 30% growth.KAR Auction Services (KAR)The first stock on our list belongs to a company in the second-hand vehicle market. KAR Auction Services operates a marketplace – both online and in the physical world – for used vehicles. The company sells to both individual and business buyers, people looking for a car to drive and garages looking to source parts for the shop floor. KAR sold over 3.7 million vehicles in 2019, bringing in $2.8 billion in auction revenue.KAR shares have been hit hard by the coronavirus epidemic. The combination of economic shutdowns and social lockdowns have not just put a hold on car sales – they have simply reduced the need for vehicles.Q1 earnings showed a 6% reduction in revenue, to $645.5 million, and a collapse in net income to $2.8 million from $15.3 million in the year-ago quarter. As noted, these steep reductions are attributable to the effects of the pandemic response. KAR shares are still down 38% year-to-date, badly underperforming the broader markets.However, JPM’s analyst Ryan Brinkman believes the current downturn is the time to buy in to KAR shares. The low price offers an attractive point of entry, and the stock has a clear path forward when economic activity resumes. Brinkman writes, “We believe that once stay-at-home orders are lifted and the situation moves from being one of a unique public health crisis to that of a more familiar economic downturn, aftermarket end-markets, including auctions, will earn their reputation for resiliency. People will drive again substantially similar to before, and volumes will return to salvage auctions.”Along with that optimistic assessment, Brinkman upgrades KAR from Neutral to Buy. His $19 price target suggests a strong 46% upside potential in the next 12 months. (To watch Brinkman’s track record, click here)Overall, KAR shares hold a Moderate Buy rating from the analyst consensus, which breaks down into 4 Buy reviews and 3 Holds. While the analyst corps is somewhat divided, their average price target is in line with Brinkman’s. (See KAR stock analysis at TipRanks)J2 Global Communications (JCOM)Next up is an internet communications company. J2 Global owns a diverse portfolio of 40+ online content brands, including IGN, Mashable, PCMag, BabyCenter, Everyday Health among others. In addition, J2 also runs a Cloud Service business, offering eFax and eVoice among other online services. The company boasts nearly $1.5 billion in annual revenue, and saw Q4 earnings rise to $2.19 per share.The Q4 earnings were the highest in two years, and capped a full year of rising earnings. Q4 is typically J2’s strongest quarter, while Q1 is typically the weakest, so the $1.35 estimate for Q1 earnings is less indicative of poor performance than one may think at first. On an important note, that Q1 estimate represents a modest increase of 1.5% year-over-year.JCOM shares’ price performance has roughly mirrored the broader market’s during the past three months. JCOM lost 35% in the initial slide, and has risen 21% from its trough.Initiating coverage of the stock for JPM, Cory Carpenter set a Buy rating, with a $105 price target that indicates room for 32% upside growth. (To watch Carpenter’s track record, click here)Supporting his stance, Carpenter notes the company’s strong Cloud position, writing, “We believe Cloud Services is well positioned to capitalize on growing security & privacy needs, with bundling & cross-sell potential, and we like that Digital Media monetizes through multiple rents—ads, subs, & affiliate commerce.”Key drivers for Carpenter's bull thesis include: "1) Total growth strategy drives sustainable growth, with $1B+ capital to deploy [...] 2) Diversified portfolio of leading Cloud Services & Digital Media brands. [...] 3) Strong FCF generator with M&A flywheel. JCOM prioritizes FCF, not growth at all costs, which it largely redeploys into M&A. JCOM’s 40% EBITDA margin is driven by Cloud Services’ ~50% margin and Digital Media’s ~35% margin."Carpenter is broadly in line with the rest of Wall Street, which has assigned JCOM more "buy" ratings than "holds" over the past three month -- and sees the stock growing about 26% over the next 12 months, to a target price of $101.30. (See J2 Global stock analysis on TipRanks)Montage Resources Corporation (MR)Last on our list is a small-cap hydrocarbon exploration and production company. Montage is based in the Appalachian region of Pennsylvania, Ohio, and West Virginia, where it operates natural gas and crude oil drilling wells. Montage holds over 195,000 undeveloped core acres, and operates 325 actively producing horizontal wells. The value of the company’s holdings is clear from its stock performance; in the last three months, while the markets have generally slid into a bear cycle, MR shares have gained 55%.Even with the COVID-19 epidemic and the collapse of oil markets, MR was able to increase its net daily production during Q1, reaching 6610.7 MMcfe. This was above both company guidance and analyst estimates. Quarterly income of $62.7 million also beat the expectations. The company has curtailed some production in low-margin crude oil, to compensate for the soft oil market prices.Analyst Arun Jayaram, reviewing MR for JPM, upgraded his stance on the shares from Neutral to Buy. His $8 price target implies a 43% upside growth potential for the coming year. (To watch Jayaram’s track record, click here)Jayaram is clear on his reasons for upgrading this stock. He says of MR, “We expect the market to largely look through negative estimate revision risk to 2020 forecasts to the emerging bullish natural gas narrative in 2021… Meanwhile, the company’s FCF yield of 23% leads the peer group and is well above the peer group average of 10%...”The Strong Buy analyst consensus on MR shares is based on 5 recent reviews, including 4 Buys and a single Hold. The company’s strong natural gas production is tangible asset, and its enviable free cash flow is attractive for investors. Shares are selling for $5.59, while the average price target of $6.22 suggests a modest upside of 1.6%. (See MR stock analysis at TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

A large-scale attack campaign has targeted over 900,000 WordPress websites through vulnerabilities in plugins and themes, WordPress security company Defiant revealed this week.

read more

The Czech Republic and the United States have signed a joint declaration Wednesday for cooperating on security of 5G technology.

read more

Popular communications platform provider Zoom Video announced on Thursday that it has acquired secure messaging and file-sharing service Keybase for an undisclosed sum. The move is the latest by the company as it attempts to bolster the security of its offerings and build in end-to-end encryption that can scale to the company’s massive user base.

read more

Recorded Future this week announced the availability of Express, a free web browser extension designed to help security teams prioritize vulnerability patching and alerts from security information and event management (SIEM) tools.

read more

North Korea-linked hacking group Lazarus has been leveraging a Mac variant of the Dacls Remote Access Trojan (RAT), Malwarebytes reports.

read more

New York state's top prosecutor on Thursday announced that the company Zoom would improve security measures, after flaws were detected as the video conferencing platform soared in popularity amid the coronavirus pandemic.

read more

Threat actors are actively targeting a vulnerability in the Elementor Pro plugin for WordPress to compromise websites, WordPress security company Defiant warned this week.

read more

More than 30 technology and telecom companies announced this week that they have formed a new alliance, the Open RAN Policy Coalition, that calls for open and interoperable 5G systems.

read more

Google this week announced that Google Authenticator users can now transfer 2-Step Verification (2SV) secrets between devices.

The new feature is meant to make it easier for users to manage their Google Authenticator 2SV codes across multiple devices.

read more

Nigerian cybercriminals specialized in business email compromise (BEC) attacks were observed leveraging COVID-19 lures in recent attacks on healthcare and government organizations, Palo Alto Networks reveals.

read more

Happy Environment Day 2016 As the title says, I would like to wish all of you an very happy environment day. Ideally speaking, every day of the year should be environment day isn’t it? You bet! Well we are definitely not in an ideal world. So we really need to think ways we can contribute to […]

What lettuce comes to your mind, when I say the word lettuce? Go on, take a minute. If you thought Iceberg lettuce, you aren’t alone. Iceberg is (or used to be) the defacto standard when it comes lettuce.  Iceberg lettuce has its crunch but if you look beyond the crunch, nutrient values that is, you will […]

  Pollination and its importance Without pollination, you can’t have the fruits of your effort (pun intended as always ;-). Pollination is a process where the pollen from the male parts of the flower are transferred to female flower or female parts of the flower. This step has to happen for fruit set to happen. […]

Motorcycle Rally Grows

Underpins company plan to expand commercialization and definitive manufacturing relationships

American Eagle Auto Body, a Los Angeles-based auto shop, is the winner of the City Beat News Spectrum Award for Excellence in Customer Service.

Generators for sale in preparation for Hurricane Matthew

Biker Next is Dating VIP's latest club that seeks to bring together everyone who's interested in biking - feel the wind and the open road with your partner!

Sanford, Florida Power Sports dealership has 2017 Can-Am Maverick's available for sale.

Extreme endurance motorcycle rider to attempt 9th world record, "Greatest Distance on a Motorcycle in 24 Hours (Individual)" this weekend in Uvalde, Texas. Follow live at www.carlreese.net starting on February 24, 2017.

Sanford, Florida Power Sports dealership participates in Yamaha pre-order program.

Sanford, Florida Power Sports Dealership Welcomes Cristy Lee for the Kickoff of "Tour de Florida"

Motorcycle enthusiasts can now experience another bucket-list journey of a lifetime.